Mantle mETH, the liquid staking token of the Mantle Network, has achieved a historic milestone by being added to the balance sheet of Beyond Medical Technologies, a publicly traded company. This marks the first time a Liquid Staking Token (LST) has been formally incorporated into a public company's treasury.
Mantle is a high-performance Ethereum Layer 2 network, and its mETH token represents staked Ethereum that remains liquid and usable in DeFi, allowing holders to earn staking rewards while maintaining flexibility to trade or use the token in decentralized applications.
Beyond Medical Technologies, through its subsidiary Republic Technologies, converted a significant portion of its ETH holdings into mETH to pursue an Ethereum-based crypto treasury strategy that combines yield generation with liquidity. This move signals a shift in how public companies approach managing digital asset treasury strategies, incorporating more sophisticated DeFi products beyond simple spot crypto holdings.
The partnership between Mantle and Republic Technologies also reflects increasing institutional conviction in Ethereum-native yield infrastructure. Republic Technologies is the first publicly listed company to build a treasury strategy centered on Ethereum, distinguishing itself from Bitcoin-focused firms. The collaboration aims to unlock institutional-grade yield and utility through mETH, supported by a robust validator infrastructure and composable capital-efficient framework.
This development is expected to pave the way for other corporations to consider similar strategies as regulatory clarity improves and the LST market matures. However, risks such as market volatility, smart contract vulnerabilities, and regulatory uncertainty remain considerations.
Beyond Medical Technologies’ milestone highlights growing institutional adoption of LSTs and bridges decentralized finance innovations with traditional corporate finance, advancing the maturation and legitimacy of digital assets in institutional portfolios.
